Sagility Q1 FY27 net profit rises 45.9% to ₹2,168 million
Sagility Limited delivered strong Q1 FY27 results with net profit rising 45.9% to ₹2,168 million and revenue growing 27.6% to ₹19,635 million. Organic growth was 27.3%, supported by expansion in existing client relationships. The company absorbed a 120 bps estimated annual impact from minimum wage revisions in Karnataka and Telangana while maintaining a 24% adjusted EBITDA margin. The recent CareSeed acquisition added 26 mid-market clients, enhancing capabilities in quality analytics and HEDIS reporting.

*this image is generated using AI for illustrative purposes only.
Sagility Limited reported a consolidated net profit of ₹2,168 million for the quarter ended June 30, 2026, marking a 45.9% increase from ₹1,486 million in the corresponding period of the previous year. Revenue from operations grew 27.6% year-on-year to ₹19,635 million, driven by a 27.3% organic growth excluding the recent CareSeed acquisition. The company’s adjusted EBITDA for the quarter stood at ₹4,716 million, representing a margin of 24.0% and a year-on-year growth of 27.9%, while adjusted profit after tax (PAT) increased 35.1% to ₹2,697 million. This strong performance reflects robust demand in its core healthcare services segments and effective cost management despite higher employee benefit costs due to statutory minimum wage revisions in Karnataka and Telangana.
Consolidated Financial Performance
Basic earnings per share (EPS) rose to ₹0.46 from ₹0.32 in the prior year, while adjusted EPS grew 35.1% to ₹0.58. Total comprehensive income for the period was ₹2,614.10 million, compared to ₹1,483.50 million in Q1 FY26. The Board of Directors approved the unaudited standalone and consolidated financial results for the quarter on July 21, 2026. Operating cash flow remained strong at ₹3,161 million, translating into an EBITDA-to-cash conversion of approximately 70%. Collections improved with Days Sales Outstanding (DSO) reducing to 80 days from 87 days in Q4 FY26.
The following table summarises the key financial metrics for the period:
| Metric (₹ in millions) | Q1 FY27 | Q1 FY26 | YoY Growth |
|---|---|---|---|
| Revenue from Operations | 19,635.00 | 15,389.00 | 27.6% |
| Net Profit | 2,168.00 | 1,486.00 | 45.9% |
| Reported EBITDA | 4,400.00 | 2,840.00 | — |
| Reported EBITDA Margin | 22.32% | 18.47% | — |
| Adjusted EBITDA | 4,716.00 | 3,687.00 | 27.9% |
| Adjusted EBITDA Margin | 24.0% | — | — |
| Adjusted PAT | 2,697.00 | 1,997.00 | 35.1% |
| Basic EPS (₹) | 0.46 | 0.32 | 43.8% |
Strategic Developments and M&A
Sagility completed the acquisition of CareSeed LLC, a U.S.-based healthcare technology company, on June 11, 2026. The provisional purchase consideration recognized was ₹2,032.51 million, with a total contractual consideration of ₹2,873.38 million. The acquisition added 26 new client groups in Q1 FY27, bringing the total active client base to 109. CareSeed contributes capabilities in HEDIS reporting and quality analytics, strengthening Sagility’s position in Medicare Advantage plans. As of June 30, 2026, the company employed 47,307 people across 29 delivery centers in 5 countries. Quarterly voluntary attrition improved significantly to 28.6% from 38.1% in Q4 FY26.
Exceptional Items and Expenses
The company recognized an exceptional item of ₹150.89 million during the quarter, relating to the past service cost for the re-measurement of gratuity and leave encashment liabilities. This expense arose due to revised minimum wage rates notified by the state governments of Karnataka and Telangana effective May and June 2026. Management estimates an incremental impact of approximately 120 basis points on adjusted EBITDA for FY27 from these wage revisions. Total expenses for the quarter increased to ₹16,752.39 million from ₹13,384.49 million in the year-ago period, primarily due to higher employee benefit costs and annual salary increases implemented in April 2026.
Dividend Proposal
The Board has proposed a final dividend of ₹0.10 per equity share for the year ended March 31, 2026. This payout is subject to shareholder approval at the upcoming Annual General Meeting and is expected to result in a cash outflow of approximately ₹468.13 million.
What the Numbers Show
The expansion in adjusted EBITDA margin to 24.0% indicates that operating leverage is improving even as absolute costs rise. While total expenses grew by approximately 25.1%, revenue growth outpaced this at 27.6%, leading to broader margins. The significant jump in net profit (45.9%) compared to revenue growth (27.6%) suggests that fixed costs are being spread over a larger revenue base, enhancing profitability efficiency. Favorable foreign exchange movements contributed more than 100 basis points to the margin, offsetting headwinds from statutory wage hikes and seasonal normalization of open enrolment volumes.
Regulatory Compliance
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sagility Limited informed the exchanges that the video recording of the investor/analyst webinar held on Tuesday, July 21, 2026, at 7:30 p.m. (IST), is available on the company's website. Additionally, pursuant to Regulation 47, newspaper advertisements regarding the results were published in Financial Express and Vishwavani News on July 23, 2026.
Historical Stock Returns for Sagility
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.42% | -1.96% | +1.15% | -12.20% | -2.89% | +46.73% |
How will the full-year impact of the 120 basis point EBITDA margin pressure from Karnataka and Telangana wage revisions affect Sagility's profitability guidance for FY27?
What specific integration milestones and revenue synergies are expected from the CareSeed acquisition in the upcoming quarters to justify the remaining contractual consideration?
Can Sagility sustain its improved voluntary attrition rate of 28.6% amidst industry-wide talent competition, and how might this influence future wage inflation pressures?


































